Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.

Thanapprapasr K, Nartthanarung A, Thanapprapasr D, Jinawath A.

PLoS One. 2017 Aug 28;12(8):e0182989. doi: 10.1371/journal.pone.0182989. eCollection 2017. Erratum in: PLoS One. 2017 Nov 29;12 (11):e0188991.


PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.

Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, Ali-Fehmi R, Coleman RL, Sood AK.

Mol Cancer Ther. 2015 Jun;14(6):1466-1475. doi: 10.1158/1535-7163.MCT-14-1077. Epub 2015 Apr 1.


Age and survival of cervical cancer patients with bone metastasis.

Nartthanarung A, Thanapprapasr K, Udomsubpayakul U, Thanapprapasr D.

Asian Pac J Cancer Prev. 2014;15(19):8401-4.


Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.

Stone RL, Baggerly KA, Armaiz-Pena GN, Kang Y, Sanguino AM, Thanapprapasr D, Dalton HJ, Bottsford-Miller J, Zand B, Akbani R, Diao L, Nick AM, DeGeest K, Lopez-Berestein G, Coleman RL, Lutgendorf S, Sood AK.

Cancer Biol Ther. 2014 Jul;15(7):919-29. doi: 10.4161/cbt.28882. Epub 2014 Apr 23.


Biologic effects of platelet-derived growth factor receptor α blockade in uterine cancer.

Roh JW, Huang J, Hu W, Yang X, Jennings NB, Sehgal V, Sohn BH, Han HD, Lee SJ, Thanapprapasr D, Bottsford-Miller J, Zand B, Dalton HJ, Previs RA, Davis AN, Matsuo K, Lee JS, Ram P, Coleman RL, Sood AK.

Clin Cancer Res. 2014 May 15;20(10):2740-50. doi: 10.1158/1078-0432.CCR-13-2507. Epub 2014 Mar 14.


Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.

Huang J, Hu W, Bottsford-Miller J, Liu T, Han HD, Zand B, Pradeep S, Roh JW, Thanapprapasr D, Dalton HJ, Pecot CV, Rupaimoole R, Lu C, Fellman B, Urbauer D, Kang Y, Jennings NB, Huang L, Deavers MT, Broaddus R, Coleman RL, Sood AK.

Clin Cancer Res. 2014 Apr 1;20(7):1846-55. doi: 10.1158/1078-0432.CCR-13-2141. Epub 2014 Jan 31.


Molecular therapy as a future strategy in endometrial cancer.

Thanapprapasr D, Thanapprapasr K.

Asian Pac J Cancer Prev. 2013;14(6):3419-23. Review.


Targeted endometrial cancer therapy as a future prospect.

Thanapprapasr D, Cheewakriangkrai C, Likittanasombut P, Thanapprapasr K, Mutch DG.

Womens Health (Lond). 2013 Mar;9(2):189-99. doi: 10.2217/whe.13.4.


Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.

Lee SJ, Ghosh SC, Han HD, Stone RL, Bottsford-Miller J, Shen DY, Auzenne EJ, Lopez-Araujo A, Lu C, Nishimura M, Pecot CV, Zand B, Thanapprapasr D, Jennings NB, Kang Y, Huang J, Hu W, Klostergaard J, Sood AK.

Clin Cancer Res. 2012 Aug 1;18(15):4114-21. doi: 10.1158/1078-0432.CCR-11-3250. Epub 2012 Jun 12.


Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study.

Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool C, Tanapat Y, Therasakvichya S, Hamontri S, Linasmita V, Bunyapipat S, Chindavijak S, Ittiwisavakul K, Khemapech N, Suekwattana P, Thanapprapasr D, Lumbiganon P.

BJOG. 2012 May;119(6):672-7. doi: 10.1111/j.1471-0528.2012.03298.x.


Moving beyond VEGF for anti-angiogenesis strategies in gynecologic cancer.

Thanapprapasr D, Hu W, Sood AK, Coleman RL.

Curr Pharm Des. 2012;18(19):2713-9. Review.


Cervical cancer screening behaviours among Thai women: results from a cross-sectional survey of 2112 healthcare providers at Ramathibodi Hospital, Thailand.

Thanapprapasr D, Deesamer S, Sujintawong S, Udomsubpayakul U, Wilailak S.

Eur J Cancer Care (Engl). 2012 Jul;21(4):542-7. doi: 10.1111/j.1365-2354.2012.01333.x. Epub 2012 Feb 8.


Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women.

Charakorn C, Rattanasiri S, Lertkhachonsuk AA, Thanapprapasr D, Chittithaworn S, Wilailak S.

Asia Pac J Clin Oncol. 2011 Jun;7(2):160-7. doi: 10.1111/j.1743-7563.2011.01392.x.


Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.

Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, Sabnis N, Deavers MT, Lee JS, Ellis LM, Lopez-Berestein G, McConathy WJ, Prokai L, Lacko AG, Sood AK.

Neoplasia. 2011 Apr;13(4):309-19.


Comparison of outcomes for patients with cervical cancer who developed bone metastasis after the primary treatment with concurrent chemoradiation versus radiation therapy alone.

Nartthanarung A, Thanapprapasr D.

Int J Gynecol Cancer. 2010 Nov;20(8):1386-90. doi: 10.1111/IGC.0b013e3181ef8f4d.


Female hospital-based healthcare professionals' knowledge of cervical cancer, HPV and attitudes towards HPV vaccination.

Thanapprapasr D, Chittithaworn S, Lertkhachonsuk AA, Udomsubpayakul U, Wilailak S.

Asian Pac J Cancer Prev. 2010;11(2):429-33.


Bone metastasis in cervical cancer patients over a 10-year period.

Thanapprapasr D, Nartthanarung A, Likittanasombut P, Na Ayudhya NI, Charakorn C, Udomsubpayakul U, Subhadarbandhu T, Wilailak S.

Int J Gynecol Cancer. 2010 Apr;20(3):373-8. doi: 10.1111/IGC.0b013e3181d4a0a1.


Can vaginal misoprostol effectively increase rate of a satisfactory colposcopy? A randomized double-blind placebo-controlled trial.

Thanapprapasr D, Wilailak S, Ayudhya NI, Lertkhachonsuk AA, Likittanasombut P, Chittithaworn S, Charakorn C, Weerakiet S.

Jpn J Clin Oncol. 2010 Mar;40(3):203-7. doi: 10.1093/jjco/hyp140. Epub 2009 Oct 29.


Supplemental Content

Loading ...
Support Center